18-10691359-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_001378183.1(PIEZO2):c.7215C>T(p.Ala2405Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.324 in 1,610,936 control chromosomes in the GnomAD database, including 88,549 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.27 ( 6284 hom., cov: 31)
Exomes 𝑓: 0.33 ( 82265 hom. )
Consequence
PIEZO2
NM_001378183.1 synonymous
NM_001378183.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.584
Publications
17 publications found
Genes affected
PIEZO2 (HGNC:26270): (piezo type mechanosensitive ion channel component 2) The protein encoded by this gene contains more than thirty transmembrane domains and likely functions as part of mechanically-activated (MA) cation channels. These channels serve to connect mechanical forces to biological signals. The encoded protein quickly adapts MA currents in somatosensory neurons. Defects in this gene are a cause of type 5 distal arthrogryposis. Several alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known. [provided by RefSeq, Feb 2014]
PIEZO2 Gene-Disease associations (from GenCC):
- Gordon syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
- arthrogryposis, distal, with impaired proprioception and touchInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Illumina, Ambry Genetics
- arthrogryposis- oculomotor limitation-electroretinal anomalies syndromeInheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
- connective tissue disorderInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- Marden-Walker syndromeInheritance: AR, AD Classification: MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant 18-10691359-G-A is Benign according to our data. Variant chr18-10691359-G-A is described in ClinVar as Benign. ClinVar VariationId is 261526.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.584 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.35 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PIEZO2 | NM_001378183.1 | c.7215C>T | p.Ala2405Ala | synonymous_variant | Exon 48 of 56 | ENST00000674853.1 | NP_001365112.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PIEZO2 | ENST00000674853.1 | c.7215C>T | p.Ala2405Ala | synonymous_variant | Exon 48 of 56 | NM_001378183.1 | ENSP00000501957.1 |
Frequencies
GnomAD3 genomes AF: 0.274 AC: 41579AN: 151860Hom.: 6282 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
41579
AN:
151860
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.282 AC: 70105AN: 248420 AF XY: 0.289 show subpopulations
GnomAD2 exomes
AF:
AC:
70105
AN:
248420
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.330 AC: 480888AN: 1458956Hom.: 82265 Cov.: 35 AF XY: 0.329 AC XY: 238437AN XY: 725722 show subpopulations
GnomAD4 exome
AF:
AC:
480888
AN:
1458956
Hom.:
Cov.:
35
AF XY:
AC XY:
238437
AN XY:
725722
show subpopulations
African (AFR)
AF:
AC:
5021
AN:
33360
American (AMR)
AF:
AC:
8186
AN:
44382
Ashkenazi Jewish (ASJ)
AF:
AC:
9021
AN:
26078
East Asian (EAS)
AF:
AC:
5427
AN:
39508
South Asian (SAS)
AF:
AC:
22282
AN:
85700
European-Finnish (FIN)
AF:
AC:
17171
AN:
53368
Middle Eastern (MID)
AF:
AC:
1600
AN:
5758
European-Non Finnish (NFE)
AF:
AC:
393552
AN:
1110524
Other (OTH)
AF:
AC:
18628
AN:
60278
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
15332
30663
45995
61326
76658
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
12268
24536
36804
49072
61340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.274 AC: 41589AN: 151980Hom.: 6284 Cov.: 31 AF XY: 0.270 AC XY: 20066AN XY: 74248 show subpopulations
GnomAD4 genome
AF:
AC:
41589
AN:
151980
Hom.:
Cov.:
31
AF XY:
AC XY:
20066
AN XY:
74248
show subpopulations
African (AFR)
AF:
AC:
6587
AN:
41456
American (AMR)
AF:
AC:
3628
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
AC:
1233
AN:
3470
East Asian (EAS)
AF:
AC:
560
AN:
5166
South Asian (SAS)
AF:
AC:
1150
AN:
4822
European-Finnish (FIN)
AF:
AC:
3405
AN:
10532
Middle Eastern (MID)
AF:
AC:
77
AN:
294
European-Non Finnish (NFE)
AF:
AC:
24049
AN:
67964
Other (OTH)
AF:
AC:
601
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1527
3054
4581
6108
7635
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
434
868
1302
1736
2170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
595
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Oct 30, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Gordon syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Marden-Walker syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Arthrogryposis, distal, with impaired proprioception and touch Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.